Boston Scientific Corporation (FRA:BSX)

Market Cap	127.48B
Revenue (ttm)	15.75B
Net Income (ttm)	2.13B
Shares Out	n/a
EPS (ttm)	1.43
PE Ratio	59.77
Forward PE	31.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160
Average Volume	1,180
Open	82.60
Previous Close	84.40
Day's Range	82.60 - 84.80
52-Week Range	75.20 - 104.00
Beta	n/a
RSI	55.61
Earnings Date	Oct 22, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD